Vanguard Fiduciary Trust’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$921K Buy
463,005
+19,340
+4% +$27.9K ﹤0.01% 3058
2026
Q1
$563K Buy
+443,665
New +$835K ﹤0.01% 3176

Other funds holding HCAT

Vanguard Fiduciary Trust's HCAT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Health Catalyst (HCAT) stake by 4.4% in Q2 2026, buying an estimated $27.9K and bringing the position to 463,005 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

Vanguard Fiduciary Trust first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Vanguard Fiduciary Trust held 463,005 shares of Health Catalyst worth $921K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 19,340 Health Catalyst shares in Q2 2026, an estimated $27.9K.
  • Health Catalyst made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3058 holding.
  • Vanguard Fiduciary Trust first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.